相关实验视频

Updated: Jul 21, 2025

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on: July 29, 2016

过度表达MTM1可以预防和逆转与BIN1相关的中核肌病

Quentin Giraud¹, Coralie Spiegelhalter¹, Nadia Messaddeq¹

¹Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), CNRS UMR7104, INSERM U1258, Université de Strasbourg, 67404, Illkirch, France.

Brain : a journal of neurology

|July 25, 2023

概括

使用腺关联病毒媒介性肌管激素 (AAV-MTM1) 的基因疗法在治疗与BIN1相关的中心核肌病 (CNM) 方面表现有前途,通过部分逆转肌肉疲弱并改善T管组织.

科学领域:

神经学神经学
遗传学遗传学是一种遗传学.
分子生物学分子生物学

背景情况:

中核和肌管神经病变 (CNM) 是一种严重的遗传疾病,其特征是肌肉软弱和肌纤维失调.
在MTM1,BIN1和DNM2中的突变,这些参与脂质和膜动态的蛋白质,导致CNM.
目前,对于CNM没有有效的治疗方法.

研究的目的:

为了评估腺相关病毒介导的肌素 (AAV-MTM1) 过度表达作为BIN1和DNM2-CNM的治疗策略.
研究MTM1在CNM相关小鼠模型中的治疗潜力.

主要方法:

腺相关病毒介导的MTM1 (AAV-MTM1) 过度表达被用于BIN1-和DNM2-CNM的小鼠模型.
通过分析肌肉病理,肌纤维大小和T管组织来评估治疗效果.
研究了MTM1的脂质酸酶活性在治疗救援中的作用.

主要成果:

早期系统性AAV-MTM1的使用阻止了Bin1mck-/-小鼠中CNM的发展.
晚期肌内AAV-MTM1在4周内在Bin1mck-/-小鼠中部分逆转了已建立的表型.
在DNM2-CNM小鼠模型中,AAV-MTM1没有改善表型.
MTM1的脂质酸酶活性对于拯救肌肉缩和低缩至关重要,但不是肌纤维失调的关键.
提升T管组织与正常化的dysferlin和caveolin水平相关.

结论:

AAV-MTM1基因治疗是一种潜在的治疗策略,用于BIN1相关的CNM.
对于CNM救援的特定方面来说,MTM1的酶活性至关重要.
这些发现支持在BIN1-CNM患者中对AAV-MTM1的临床研究.

关键词:

出生性肌肉病变 (congenital myopathy) 是一种先天性肌肉病变.基因治疗的基因疗法在mTOROR中使用mTOR.神经肌肉疾病神经肌肉疾病这是骨肌肉的骨架肌肉.

更多相关视频

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Satellite Stem Cells and Muscular Dystrophy

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...